🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Status
Unknown
Location
Shandong Second Provincial General Hospital
Start Date
2021-09-06
Trial ID
NCT05420493
Treatments Being Tested
The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Status
Not Yet Recruiting
Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
Start Date
2025-09-30
Trial ID
NCT07161193
Treatments Being Tested
The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-11-29
Trial ID
NCT06685042
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This phase I trial studies the side effects and best dose of BCMA CART cell...
Status
Unknown
Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Start Date
2018-06-02
Trial ID
NCT03767725
Treatments Being Tested
Establishing real-world data of Chinese patients with CD19-positive relapse...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07637929
Treatments Being Tested
This is a single arm,open-label, non-randomized phase 2 study to determine ...
Status
Unknown
Location
Shanghai Mengchao Cancer Hospital
Start Date
2021-06-04
Trial ID
NCT05472610
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
Subjects on this study have a type of lymph gland cancer called Non-Hodgkin...
Status
Recruiting
Location
Houston Methodist Hospital
Start Date
2014-02
Trial ID
NCT01853631